• This record comes from PubMed

Temperature-Controlled Catheter Ablation for Paroxysmal Atrial Fibrillation: the QDOT-MICRO Workflow Sttudy

. 2021 Apr-May ; 13 (6) : 20200460. [epub] 20210430

Status PubMed-not-MEDLINE Language English Country United States Media electronic-ecollection

Document type Journal Article

BACKGROUND: A novel QDOT MICRO (Biosense Webster, Inc., Irvine, CA) catheter with optimized temperature control and microelectrodes was designed to incorporate real-time temperature sensing with contact force detection and microelectrodes to streamline ablation workflow. The QDOT-MICRO feasibility study evaluated the workflow, performance, and safety of temperature-controlled catheter ablation in patients with symptomatic paroxysmal atrial fibrillation with conventional ablation setting. METHODS: This was a non-randomized, single-arm, first-in-human study. The primary outcome was pulmonary vein isolation (PVI), confirmed by entrance block after adenosine and/or isoproterenol challenge. Safety outcomes included incidences of early-onset primary adverse events (AEs) and serious adverse device effects (SADEs). Device performance was evaluated via physician survey. RESULTS: All evaluated patients (n = 42) displayed 100% PVI. Two primary AEs (4.8%) were reported: 1 pericarditis and 1 vascular pseudoaneurysm. An additional SADE of localized infection was reported in 1 patient. No stroke, patient deaths, or other unanticipated AEs were reported. Average power delivered was 32.1±4.1 W, with a mean temperature of 40.8°C±1.6°C. Mean procedure (including 20-minute wait), fluoroscopy, and radiofrequency application times were 129.8, 6.7, and 34.0 minutes, respectively. On device performance, physicians reported overall satisfactory performance with the new catheter, with highest scores for satisfaction and usefulness of the temperature indicator. CONCLUSIONS: Initial clinical experience with the novel catheter showed 100% acute PVI success and acceptable safety and device performance in temperature-controlled ablation mode. There were no deaths, stroke, or unanticipated AEs. Fluoroscopy and procedural times were short and similar or better than reported for prior generation catheters.

See more in PubMed

Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019 Aug 06;140 (6) PubMed

Nielsen Jens Cosedis, Johannessen Arne, Raatikainen Pekka, Hindricks Gerhard, Walfridsson Håkan, Pehrson Steen Michael, Englund Anders, Hartikainen Juha, Mortensen Leif Spange, Hansen Peter Steen. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial. Heart. 2017 Mar;103 (5):368–376. PubMed

Natale Andrea, Reddy Vivek Y, Monir George, Wilber David J, Lindsay Bruce D, McElderry H Thomas, Kantipudi Charan, Mansour Moussa C, Melby Daniel P, Packer Douglas L, Nakagawa Hiroshi, Zhang Baohui, Stagg Robert B, Boo Lee Ming, Marchlinski Francis E. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol. 2014 Aug 19;64 (7):647–56. PubMed

Macle Laurent, Frame Diana, Gache Larry M, Monir George, Pollak Scott J, Boo Lee Ming. Atrial fibrillation ablation with a spring sensor-irrigated contact force-sensing catheter compared with other ablation catheters: systematic literature review and meta-analysis. BMJ Open. 2019 Jun 11;9 (6) PubMed PMC

Chinitz Larry A, Melby Daniel P, Marchlinski Francis E, Delaughter Craig, Fishel Robert S, Monir George, Patel Anshul M, Gibson Douglas N, Athill Charles A, Ming Boo Lee, Stagg Robert, Natale Andrea. Safety and efficiency of porous-tip contact-force catheter for drug-refractory symptomatic paroxysmal atrial fibrillation ablation: results from the SMART SF trial. Europace. 2018 Nov 01;20 (FI_3):f392–f400. PubMed

Guerra Jose M, Jorge Esther, Raga Silvia, Gálvez-Montón Carolina, Alonso-Martín Concepción, Rodríguez-Font Enrique, Cinca Juan, Viñolas Xavier. Effects of open-irrigated radiofrequency ablation catheter design on lesion formation and complications: in vitro comparison of 6 different devices. J Cardiovasc Electrophysiol. 2013 Oct;24 (10):1157–62. PubMed

Reddy Vivek Y, Grimaldi Massimo, De Potter Tom, Vijgen Johan M, Bulava Alan, Duytschaever Mattias Francis, Martinek Martin, Natale Andrea, Knecht Sebastien, Neuzil Petr, Pürerfellner Helmut. Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin Electrophysiol. 2019 Jul;5 (7):778–786. PubMed

Calkins Hugh, Hindricks Gerhard, Cappato Riccardo, Kim Young-Hoon, Saad Eduardo B, Aguinaga Luis, Akar Joseph G, Badhwar Vinay, Brugada Josep, Camm John, Chen Peng-Sheng, Chen Shih-Ann, Chung Mina K, Nielsen Jens Cosedis, Curtis Anne B, Davies D Wyn, Day John D, d'Avila André, de Groot N M S Natasja, Di Biase Luigi, Duytschaever Mattias, Edgerton James R, Ellenbogen Kenneth A, Ellinor Patrick T, Ernst Sabine, Fenelon Guilherme, Gerstenfeld Edward P, Haines David E, Haissaguerre Michel, Helm Robert H, Hylek Elaine, Jackman Warren M, Jalife Jose, Kalman Jonathan M, Kautzner Josef, Kottkamp Hans, Kuck Karl Heinz, Kumagai Koichiro, Lee Richard, Lewalter Thorsten, Lindsay Bruce D, Macle Laurent, Mansour Moussa, Marchlinski Francis E, Michaud Gregory F, Nakagawa Hiroshi, Natale Andrea, Nattel Stanley, Okumura Ken, Packer Douglas, Pokushalov Evgeny, Reynolds Matthew R, Sanders Prashanthan, Scanavacca Mauricio, Schilling Richard, Tondo Claudio, Tsao Hsuan-Ming, Verma Atul, Wilber David J, Yamane Teiichi. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythm. 2017 Oct;33 (5):369–409. PubMed PMC

Wilber David J, Pappone Carlo, Neuzil Petr, De Paola Angelo, Marchlinski Frank, Natale Andrea, Macle Laurent, Daoud Emile G, Calkins Hugh, Hall Burr, Reddy Vivek, Augello Giuseppe, Reynolds Matthew R, Vinekar Chandan, Liu Christine Y, Berry Scott M, Berry Donald A. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010 Jan 27;303 (4):333–40. PubMed

Oza Saumil R, Hunter Tina D, Biviano Angelo B, Dandamudi Gopi, Herweg Bengt, Patel Anshul M, Pollak Scott J, Wang Huijian, Fishel Robert S. Acute safety of an open-irrigated ablation catheter with 56-hole porous tip for radiofrequency ablation of paroxysmal atrial fibrillation: analysis from 2 observational registry studies. J Cardiovasc Electrophysiol. 2014 Aug;25 (8):852–858. PubMed PMC

Theis Cathrin, Rostock Thomas, Mollnau Hanke, Sonnenschein Sebastian, Himmrich Ewald, Kämpfner Denise, Ocete Blanca Quesada, Bock Karsten, Münzel Thomas, Konrad Torsten. The Incidence of Audible Steam Pops Is Increased and Unpredictable With the ThermoCool® Surround Flow Catheter During Left Atrial Catheter Ablation: A Prospective Observational Study. J Cardiovasc Electrophysiol. 2015 Sep;26 (9):956–962. PubMed

Reddy Vivek Y, Pollak Scott, Lindsay Bruce D, McElderry H Thomas, Natale Andrea, Kantipudi Charan, Mansour Moussa, Melby Daniel P, Lakkireddy Dhanunjaya, Levy Tzachi, Izraeli David, Sangli Chithra, Wilber David. Relationship Between Catheter Stability and 12-Month Success After Pulmonary Vein Isolation: A Subanalysis of the SMART-AF Trial. JACC Clin Electrophysiol. 2016 Nov;2 (6):691–699. PubMed

Iwasawa Jin, Koruth Jacob S, Petru Jan, Dujka Libor, Kralovec Stepan, Mzourkova Katerina, Dukkipati Srinivas R, Neuzil Petr, Reddy Vivek Y. Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2017 Aug 01;70 (5):542–553. PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...